VTRVentas, Inc.

NYSE ventasreit.com


$ 41.68 $ -0.56 (-1.33 %)    

Tuesday, 16-Apr-2024 15:59:54 EDT
QQQ $ 431.36 $ 0.35 (0.08 %)
DIA $ 378.03 $ 0.67 (0.18 %)
SPY $ 503.53 $ -0.92 (-0.18 %)
TLT $ 88.33 $ -0.56 (-0.63 %)
GLD $ 221.23 $ 0.27 (0.12 %)
$ 41.68
$ 41.98
$ 0.00 x 0
$ 0.00 x 0
$ 41.45 - $ 42.13
$ 38.58 - $ 50.08
1,335,292
na
17B
$ 1.63
nm
TBD
na
na ($ 0.04)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-15-2024 12-31-2023 10-K
2 11-03-2023 09-30-2023 10-Q
3 08-04-2023 06-30-2023 10-Q
4 05-09-2023 03-31-2023 10-Q
5 02-10-2023 12-31-2022 10-K
6 11-04-2022 09-30-2022 10-Q
7 08-05-2022 06-30-2022 10-Q
8 05-06-2022 03-31-2022 10-Q
9 02-18-2022 12-31-2021 10-K
10 11-05-2021 09-30-2021 10-Q
11 08-06-2021 06-30-2021 10-Q
12 05-07-2021 03-31-2021 10-Q
13 02-23-2021 12-31-2020 10-K
14 11-06-2020 09-30-2020 10-Q
15 08-10-2020 06-30-2020 10-Q
16 05-08-2020 03-31-2020 10-Q
17 02-24-2020 12-31-2019 10-K
18 10-25-2019 09-30-2019 10-Q
19 07-26-2019 06-30-2019 10-Q
20 04-29-2019 03-31-2019 10-Q
21 02-08-2019 12-31-2018 10-K
22 10-26-2018 09-30-2018 10-Q
23 07-27-2018 06-30-2018 10-Q
24 04-27-2018 03-31-2018 10-Q
25 02-09-2018 12-31-2017 10-K
26 10-27-2017 09-30-2017 10-Q
27 07-28-2017 06-30-2017 10-Q
28 04-28-2017 03-31-2017 10-Q
29 02-14-2017 12-31-2016 10-K
30 10-28-2016 09-30-2016 10-Q
31 07-29-2016 06-30-2016 10-Q
32 04-29-2016 03-31-2016 10-Q
33 02-12-2016 12-31-2015 10-K
34 10-26-2015 09-30-2015 10-Q
35 07-27-2015 06-30-2015 10-Q
36 04-24-2015 03-31-2015 10-Q
37 02-13-2015 12-31-2014 10-K
38 10-24-2014 09-30-2014 10-Q
39 08-11-2014 06-30-2014 10-Q
40 04-29-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 evercore-isi-group-upgrades-ventas-to-outperform-announces-50-price-target

Evercore ISI Group analyst Steve Sakwa upgrades Ventas (NYSE:VTR) from In-Line to Outperform and announces $50 price target.

 wells-fargo-downgrades-ventas-to-equal-weight-announces-46-price-target

Wells Fargo analyst Connor Siversky downgrades Ventas (NYSE:VTR) from Overweight to Equal-Weight and announces $46 price tar...

 wall-streets-most-accurate-analysts-views-on-3-real-estate-stocks-with-over-4-dividend-yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often com...

 ventas-q4-normalized-ffo-per-share-076-beats-075-estimate-sales-116b-beat-115b-estimate

Ventas (NYSE:VTR) reported quarterly Normalized FFO of $0.76 per share which beat the analyst consensus estimate of $0.75 by 1....

 earnings-scheduled-for-february-14-2024

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on r...

 deutsche-bank-initiates-coverage-on-ventas-with-buy-rating-announces-price-target-of-60

Deutsche Bank analyst Omotayo Okusanya initiates coverage on Ventas (NYSE:VTR) with a Buy rating and announces Price Target ...

 b-of-a-securities-upgrades-ventas-to-buy-raises-price-target-to-53

B of A Securities analyst Joshua Dennerlein upgrades Ventas (NYSE:VTR) from Neutral to Buy and raises the price target from ...

 ventas-confirms-issues-statement-regarding-three-director-nominations-by-land--buildings-investment-management

No Shareholder Action Required at This TimeThe Ventas Board of Directors and management team are committed to acting in the bes...

 mizuho-maintains-buy-on-ventas-raises-price-target-to-56

Mizuho analyst Vikram Malhorta maintains Ventas (NYSE:VTR) with a Buy and raises the price target from $53 to $56.

 wells-fargo-maintains-overweight-on-ventas-lowers-price-target-to-47

Wells Fargo analyst Connor Siversky maintains Ventas (NYSE:VTR) with a Overweight and lowers the price target from $49 to $47.

 jim-cramer-asks-why-the-worlds-largest-healthcare-products-company-has-an-ill-advised-strategy

On CNBC’s "Mad Money Lightning Round," Jim Cramer said The Clorox Company’s (NYSE: CLX) recent quarter was "ok.&#...

 ventas-welltower-have-new-growth-in-senior-housing-portfolios-analyst-says-whats-next

With senior housing generating sequential growth, the performance of healthcare real estate investment trusts (REITs) has been ...

 expert-ratings-for-ventas
Expert Ratings for Ventas
11/07/2023 13:00:51

 appian-to-rally-around-47-here-are-10-top-analyst-forecasts-for-tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

NEW CASE INVESTIGATION